CLINICAL_TRIALS
withdrawal
· 2024-07-29
Clinical Trial Update: Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS [Phase 1, Phase 2]
Summary
The Phase 1/Phase 2 clinical trial evaluating bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for acute respiratory distress syndrome h…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Direct Biologics, LLC | Conditions: ARDS, Human | Phase 1, Phase 2 | Status: WITHDRAWN